{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:14:00Z","timestamp":1790680440952,"version":"4.1.0"},"reference-count":55,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cannabis &amp; Cannabinoid Research"],"published-print":{"date-parts":[[2025,2,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>\n                      Post-surgical pain arises following a clinical operation, often persisting throughout recovery. While current treatments reduce pain, repeated use increases the probability of adverse events. monoacylglycerol lipase (MAGL) inhibition has previously been shown to produce analgesia, either through CB\n                      <jats:sub>1<\/jats:sub>\n                      or CB\n                      <jats:sub>2<\/jats:sub>\n                      mechanisms, dependent on the underlying pain phenotype. Thus, this study investigated the analgesic potential of inhibiting MAGL, alone and in combination with the analgesic non-steroidal anti-inflammatory drug (NSAID) diclofenac sodium in a model of post-surgical pain.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Male and female C57BL\/6J mice were subjected to hindpaw incision (HPI) surgery. Mechanical allodynia, climbing, grip strength, and thermal preference were measured 24 h following HPI. The dose-dependent anti-allodynic effects of the MAGL inhibitors (irreversible MAGL inhibitor [JZL184] and selective MAGL inhibitor [MJN110]) and the NSAID diclofenac, as well as the additive potential of combined MAGL and cyclooxygenase (COX) inhibition, were assessed. Selective antagonists of CB\n                      <jats:sub>1<\/jats:sub>\n                      and CB\n                      <jats:sub>2<\/jats:sub>\n                      receptors were used to challenge the cannabinoid-receptor mechanism of JZL184. Similarly, the anti-allodynic effects of the CB\n                      <jats:sub>2<\/jats:sub>\n                      -selective agonist (LY2828360) were tested. JZL184 was administered repeatedly to determine tolerance. Finally, hindpaw cytokines were quantified\n                      <jats:italic toggle=\"yes\">via<\/jats:italic>\n                      multiplex ELISA 24 h after HPI surgery.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Approximately 24 h post-surgery, the MAGL inhibitors JZL184 (\u22654 mg\/kg) or MJN110 (\u22655 mg\/kg), as well as the NSAID diclofenac sodium (\u226516.67 mg\/kg), attenuated HPI-induced mechanical allodynia, as assessed with von Frey filaments. The anti-allodynic effects of JZL184 (40 mg\/kg) were blocked by pre-treatment of the CB\n                      <jats:sub>2<\/jats:sub>\n                      antagonist SR144528 (3 mg\/kg) but not the CB\n                      <jats:sub>1<\/jats:sub>\n                      -selective antagonist rimonabant (SR141716A; 3 mg\/kg), suggesting a CB\n                      <jats:sub>2<\/jats:sub>\n                      -mediated mechanism of anti-allodynia\n                      <jats:italic toggle=\"yes\">via<\/jats:italic>\n                      MAGL inhibition. Similarly, LY2828360 (3 mg\/kg) reduced HPI-induced allodynia. Moreover, when administered repeatedly, the anti-allodynic effects of JZL184 (8 mg\/kg) persisted and did not undergo tolerance. A separate cohort was administered a sub-analgesic dose of JZL184 (1 mg\/kg), diclofenac sodium (1.85 mg\/kg), or both compounds concurrently. This subthreshold JZL184 and diclofenac sodium combination attenuated HPI-induced allodynia, suggesting an additive drug interaction. Finally, HPI\n                      <jats:italic toggle=\"yes\">per se<\/jats:italic>\n                      increased pro-inflammatory cytokine levels, which were unaltered by MAGL inhibition despite the anti-allodynia assessed behaviorally.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>These data support simultaneously targeting endocannabinoids and COX enzymes as a potential post-operative pain management approach.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/can.2024.0088","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T11:47:16Z","timestamp":1738583236000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Combined Endocannabinoid and Cyclooxygenase Inhibition Additively Attenuates Post-Surgical Pain"],"prefix":"10.1177","volume":"10","author":[{"given":"Carl E.B.","family":"Rodriguez","sequence":"first","affiliation":[{"name":"School of Nursing, University of Connecticut, Storrs, Connecticut, USA."},{"name":"Department of Psychological Sciences, University of Connecticut, Storrs, Connecticut, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Olivia","family":"Vanegas","sequence":"additional","affiliation":[{"name":"School of Nursing, University of Connecticut, Storrs, Connecticut, USA."},{"name":"Department of Psychological Sciences, University of Connecticut, Storrs, Connecticut, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Matthew","family":"Reck","sequence":"additional","affiliation":[{"name":"School of Nursing, University of Connecticut, Storrs, Connecticut, USA."},{"name":"Department of Psychological Sciences, University of Connecticut, Storrs, Connecticut, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Schrom","sequence":"additional","affiliation":[{"name":"Department of Psychological Sciences, University of Connecticut, Storrs, Connecticut, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0764-1700","authenticated-orcid":false,"given":"Steven G.","family":"Kinsey","sequence":"additional","affiliation":[{"name":"School of Nursing, University of Connecticut, Storrs, Connecticut, USA."},{"name":"Department of Psychological Sciences, University of Connecticut, Storrs, Connecticut, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2020.07.017"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmwh.2004.08.021"},{"issue":"3","key":"e_1_3_5_4_2","article-title":"A review of potential adverse effects of long-term opioid therapy: A practitioner\u2019s guide","volume":"14","author":"Baldini A","year":"2012","unstructured":"Baldini A, , von Korff M, , Lin EH. A review of potential adverse effects of long-term opioid therapy: A practitioner\u2019s guide. Prim Care Companion CNS Disord, 2012; 14(3).","journal-title":"Prim Care Companion CNS Disord"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1186\/s41038-018-0128-x"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115714"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(97)82001-3"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1124\/pr.54.2.161"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.3390\/ph3082661"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresrev.2008.12.003"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.2174\/187152709789824660"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002268"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2007.11.006"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.129"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2012.10.013"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1209200"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1089\/can.2020.0177"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.175778"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(95)01441-1"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200310000-00041"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2013.09.055"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2005.10.020"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00184.x"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.118.252296"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(92)90004-U"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-019-2745-x"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2017.05.006"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13012"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.117.109355"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpain.2023.1150236"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.3791\/2610-v"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2008.03.001"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0270(94)90144-9"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.anes.0000264765.33673.6c"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1021\/cn400116z"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.112.201426"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-3084(00)00189-4"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.145011"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010891"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12950-018-0201-z"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.114.094649"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/nn.2616"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2008.08.007"},{"key":"e_1_3_5_44_2","first-page":"11","article-title":"Cannabinoid system and cyclooxygenases inhibitors","volume":"4","author":"P\u01ceunescu H","year":"2011","unstructured":"P\u01ceunescu H, et al. Cannabinoid system and cyclooxygenases inhibitors. J Med Life, 2011; 4:11\u201320.","journal-title":"J Med Life"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2007.02.051"},{"issue":"6","key":"e_1_3_5_46_2","first-page":"309","article-title":"Non-opioid analgesics and the endocannabinoid system","volume":"37","author":"Topuz RD","year":"2020","unstructured":"Topuz RD, , G\u00fcnd\u00fcz \u00d6, , Karada\u011f \u00c7H, et al. Non-opioid analgesics and the endocannabinoid system. Balkan Med J, 2020; 37(6):309\u2013315.","journal-title":"Balkan Med J"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-8180(01)00320-8"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.anclin.2010.02.011"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2017.0898"},{"key":"e_1_3_5_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2012.02.012"},{"key":"e_1_3_5_51_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.143487"},{"key":"e_1_3_5_52_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901929"},{"key":"e_1_3_5_53_2","doi-asserted-by":"publisher","DOI":"10.1213\/01.ANE.0000080611.29106.9E"},{"key":"e_1_3_5_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2012.04.014"},{"key":"e_1_3_5_55_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119106"},{"key":"e_1_3_5_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2022.02.006"}],"container-title":["Cannabis &amp; Cannabinoid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/can.2024.0088","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/can.2024.0088","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/can.2024.0088","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:13:49Z","timestamp":1777385629000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/can.2024.0088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2,1]]}},"alternative-id":["10.1089\/can.2024.0088"],"URL":"https:\/\/doi.org\/10.1089\/can.2024.0088","relation":{},"ISSN":["2578-5125","2378-8763"],"issn-type":[{"value":"2578-5125","type":"print"},{"value":"2378-8763","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,1]]}}}